Literature DB >> 3028971

Infections due to the human herpesviruses in southern India: a seroepidemiological survey.

A R Venkitaraman, J M Seigneurin, G M Lenoir, T J John.   

Abstract

We studied the prevalence of IgG and IgM antibodies to the human herpesviruses in a hospital-based population of 181 individuals aged 0 to 25 years, who were resident in Vellore, south India or surrounding rural areas. Antibodies to the Epstein-Barr virus (EBV) viral capsid antigen were determined by indirect immunofluorescence, while antibodies to the remaining herpesviruses were determined by enzyme-linked immunosorbent assay. The age-specific prevalence rates of IgG antibodies to EBV and cytomegalovirus (CMV) rose rapidly after birth to reach a value of over 90% by the fourth year of life. High age-specific IgM prevalence rates and geometric mean titres (GMT) of IgG antibody in children 6 months to 2 years of age, and the early median age of virus infection (1.4 years for EBV and less than 1 year for CMV) indicate that primary infection with these viruses occurs early in life. In contrast, age-specific prevalence rates of IgG antibodies to varicella-zoster virus (VZV) and herpes simplex virus (HSV) rose gradually after birth to attain maximal values of only 72% (VZV) and 83% (HSV) in the 15-25 year age group, and the median ages of infection were delayed (12.25 years for VZV and 8.2 years for HSV). The age-specific IgG prevalence rates of VZV and HSV, and of EBV and HSV showed statistically significant positive correlations, suggesting that common epidemiological factors may underlie the pattern of infections due to these groups of viruses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028971     DOI: 10.1093/ije/15.4.561

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Cytomegalovirus (CMV) mononucleosis syndrome.

Authors:  A A Bhave; M Chandy; T J John; A Sudarsanam; S Christopher; D Dennison
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

2.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

Review 3.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

4.  The age of infection with varicella-zoster virus in St Lucia, West Indies.

Authors:  G P Garnett; M J Cox; D A Bundy; J M Didier; J St Catharine
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

5.  Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.

Authors:  Batya B Davidovici; Ran D Balicer; Eyal Klement; Manfred S Green; Ella Mendelson; Zehava Smetana; Dani I Cohen
Journal:  Eur J Epidemiol       Date:  2007-08-01       Impact factor: 8.082

6.  Environmental factors related to multiple sclerosis in Indian population.

Authors:  Chaithra Malli; Lekha Pandit; Anita D'Cunha; Sharik Mustafa
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

7.  Exposure rate of VZV among women attending antenatal care clinic in Sri Lanka - a cross sectional study.

Authors:  Saluwadana Walawwe Pavithra Lakmini Daulagala; Faseeha Noordeen; Mohamed Mukthar Fathina Fara; Chathura Rathnayake; Kapila Gunawardana
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090

8.  Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania.

Authors:  Elieza Chibwe; Mariam M Mirambo; Albert Kihunrwa; Stephen E Mshana
Journal:  BMC Res Notes       Date:  2017-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.